The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Fishman, I.
* Articles by Weinstock-Guttman, B.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Fishman, I.
* Articles by Weinstock-Guttman, B.
Related Collections
* Impulse Control Disorders
J Neuropsychiatry Clin Neurosci 16:350-356, August 2004
© 2004 American Psychiatric Press, Inc.

Construct Validity and Frequency of Euphoria Sclerotica in Multiple Sclerosis

Inna Fishman, M.A., Ralph H. B. Benedict, Ph.D., Rohit Bakshi, M.D., Roger Priore, Sc.D. and Bianca Weinstock-Guttman, M.D.

Received August 21, 2002; revised March 13, 2003; accepted March 25, 2003. From the State University of New York (SUNY) Buffalo School of Medicine and Biomedical Sciences, Buffalo General Hospital, Buffalo, New York. Address correspondence to Dr. Benedict, 100 High Street, Buffalo, NY 14203; benedict{at}buffalo.edu (E-mail).

Using the Neuropsychiatric Inventory (NPI), we studied euphoria and other behavioral changes in 75 consecutive, unselected multiple sclerosis (MS) patients and 25 healthy controls. We also assessed disease duration, clinical course, physical disability, personality, depression, insight, cognition, and caregiver distress. Factor analysis identified a cluster of symptoms—labeled euphoria/disinhibition—similar to the euphoria sclerotica syndrome originally described by Charcot and others. The euphoria/disinhibition factor score was elevated in 9% of patients and associated with secondary-progressive course, low agreeableness, poor insight, impaired cognition, and high caregiver distress. Thus, we used the NPI to validate the euphoria syndrome in multiple sclerosis (MS) and determined its frequency, and its neurological and psychological correlates.




This article has been cited by other articles:


Home page
Mult SclerHome page
N Figved, R Benedict, G Klevan, K. Myhr, H. Nyland, N. Landro, J. Larsen, and D Aarsland
Relationship of cognitive impairment to psychiatric symptoms in multiple sclerosis
Multiple Sclerosis, September 1, 2008; 14(8): 1084 - 1090.
[Abstract] [PDF]


Home page
NeurologyHome page
M. P. Sanfilipo, R. H.B. Benedict, B. Weinstock-Guttman, and R. Bakshi
Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis
Neurology, March 14, 2006; 66(5): 685 - 692.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2004 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org